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1 Early drug studies that are essentially limited to assessment of 
tolerability and safety provide insufficient information for go/no-go 
decisions (Adam Cohen) 
2 The development of drugs that act on complex systems (such  
as cannabinoids) requires a pharmacological approach, rather than  
a focus on safety and tolerability (adapted from this thesis, chapter 7) 
3 Although the exact mechanism of cannabinoid induced changes 
in heart rate is unknown, this parameter is a suitable measure in the 
assessment of effect profiles of cannabinoid agonists and antagonists  
in addition to cns parameters
4 The psychiatric adverse effects that led to the desertion of 
cb¡-antagonists can provide important clues to the pathogenesis  
of psychiatric disorders, which so far have been largely neglected
5 The abandonment of cannabinoid research by many pharma-
ceutical industries deprived this research field from an important 
driving force, which is essential to unfold the full therapeutic  
potential of this important pharmacological system 
6 Renaming the cannabinoid system would benefit research  
and drug development in this field
7 rs-fmri can possibly be a useful technique for prediction  
of drug effects (this thesis, chapter 3) despite the fact that this technique 
is (still) unable to link physiological or functional processes
8 One of the characteristics of successful drug development is the 
high termination rate in preclinical/phase I stages, which indicates 
that pharma companies have an early idea of which assets are likely 
to succeed (adapted from M. Ringel, P. Tollman, G. Hersch, Boston Consulting 
Group)
9 Researchers that can build bridges between business and science 
can improve the quality and efficiency of scientific research
10 The progressive and innovative nature of science contrasts with 
the conservative organization of academic institutions 
11 The dismissal of a leading academic from a governmental drug 
advisory council*, because he expressed scientific arguments, highlights 
the danger of political involvement in scientific issues 
12 “[...] music biologically and culturally co-evolved with dance 
to serve as a technology of social bonding” (Walter Freeman, in The 
Origins of Music); therefore, impoverishment of music education in the 
Netherlands will negatively influence the social fabric of Dutch society
 
* Prof. Dr. David Nutt, former chairman of the Advisory Council on the Misuse of Drugs in the uk
